Updated:
BioProcess360 Partners
BioProcess360 Partners is a private equity asset manager headquartered in Delray Beach, United States.
BioProcess360 Partners
BioProcess360 Partners is a firm that provides investment and strategic support for bioprocessing innovations. It offers growth capital, expertise, and guidance to emerging bioprocessing technologies. Founded in 2024 in Delray Beach, Florida, the firm has made two investments, including a Series A investment in Abselion on December 04, 2024.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Delray Beach
Corporate office
Delray Beach, United States
Sector focus
Frequently asked questions
What is BioProcess360 Partners?
BioProcess360 Partners is a private equity headquartered in Delray Beach, United States.
Where is BioProcess360 Partners headquartered?
BioProcess360 Partners is headquartered in Delray Beach, United States, in the North America region.
What is BioProcess360 Partners's assets under management?
BioProcess360 Partners reports approximately Undisclosed in assets under management, as tracked by Altss.
What does Altss track for BioProcess360 Partners?
Altss maintains an OSINT-verified profile of BioProcess360 Partners covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is BioProcess360 Partners's website?
BioProcess360 Partners's public website is www.bioprocess360.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is BioProcess360 Partners?
BioProcess360 Partners is classified by Altss as a Private Equity, operating from United States within the North America region.
How does Altss source intelligence on BioProcess360 Partners?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was BioProcess360 Partners's Altss profile last updated?
BioProcess360 Partners's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: